Healthcare News
Study finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemic
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, finds.
Analysis finds weight-loss surgery may help people with obesity manage high blood pressure
People with obesity who underwent weight-loss surgery were more likely to control their high blood pressure over a 1-to-5 year follow-period compared to those who managed their high blood pressure with medications and lifestyle management.
Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds
Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD), held in Madrid, Spain (9–13 September).
Metabolic and bariatric surgery found to prevent pre-diabetes from developing into type 2 diabetes in most patients
Patients with pre-diabetes and severe obesity who had metabolic and bariatric surgery were 20 times less likely to develop full-blown type 2 diabetes over the course of 15 years than patients with the condition who did not have surgery.
Tirzepatide associated with greater weight loss in women than men
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss.
